Ensuring Thorough ct パチスロ

ct パチスロ

Basic Policy

An enterprise is required to promote the realization of a sustainable society through the creation of added value and employment that are useful to society and through autonomous and responsible actions based on fair and free competition.

Following our corporate philosophy, the Kyorin Group conducts its activities in Japan and overseas based on a high standard of corporate ethics, in ct パチスロ with both the letter and the spirit of relevant laws, regulations, and international rules.

Charter of Corporate Conduct and ct パチスロ Guidelines

Using the Corporate Ethics and ct パチスロ Guidelines, in August 2006, we formulated the Charter of Corporate Conduct and the ct パチスロ Guidelines, which were revised in April 2019 to reflect our commitment to a sustainable society and again in April 2023 to reflect the Group’s restructuring and changes including legal revisions and social developments.

1. The KYORIN Pharmaceutical Corporate Charter was developed to specify matters of corporate ethics and ct パチスロ in accordance with our corporate philosophy, and serves as the starting point for our corporate activities.
2. The ct パチスロ Guidelines complement the KYORIN Pharmaceutical Corporate Charter by clarifying the standards to be followed for sound and proper business activities.
3. The ct パチスロ Committee was established to provide overall supervision of corporate ethics and ct パチスロ systems. Each Kyorin company has a ct パチスロ promotion manager who is responsible for the understanding and instilling of corporate ethics and ct パチスロ.

We are also building a structure to promote ct パチスロ, including the establishment of a ct パチスロ Committee, which is chaired by the corporate officer responsible for ct パチスロ and led by Legal and Corporate ct パチスロ. The committee meets monthly and reports regularly on the content of its meetings to the Management Committee.

Respect for human rights

Kyorin’s respect for human rights is outlined in the Charter of Corporate Conduct and the ct パチスロ Guidelines. The Group is managed with an understanding of international norms related to human rights and with a priority on respect for the human rights of all people.

We have also established guidelines to prevent harassment including sexual harassment, harassment related to pregnancy, childbirth, childcare leave and nursing care leave, as well as for the prevention of “power harassment” by managers toward their subordinates.

Education and Training

Internal training is held to ensure an understanding of and familiarity with Kyorin’s corporate philosophy and ct パチスロ.

1. Companywide level-specific training (newly hired employees, newly appointed managers, etc.) and functional training are held to teach corporate ethics and ct パチスロ, and efforts are made to ensure that an understanding and consideration of ct パチスロ are reflected in the work performed by directors, corporate auditors and officers, and employees.
2. We have designated June and November as twice-yearly “ct パチスロ enforcement months” and are working to ensure that ct パチスロ is thoroughly understood and practiced through initiatives designated for each department and employee.

Internal whistleblowing system

The Kyorin Group has established a “Corporate Ethics Hotline” to accept inquiries, consultations, and reports regarding corporate ethics and responses to laws and regulations, etc. The Group also accepts whistleblower reports of suspected injustice or non-ct パチスロ via internal and external points of contact. We strictly maintain the confidentiality of whistleblowers, respect their privacy, and ensure that they are not disadvantaged.

Whistleblowing reports: reports: 3 in fiscal 2024

Risk Management

The ct パチスロ Group companies have established the Risk Management Committee, which is held once a month to develop a management system that seeks to prevent the occurrence of risks and handle any risks that arise.

The details of these meetings are regularly reported to the Management Committee. The Risk Management Committee oversees risk management initiatives across the entire Group, while also promoting activities to be implemented as necessary at respective divisions to build a structure to identify potential risks, reduce risks, and prevent risk events from occurring, and to minimize the damage from risk events that do occur unavoidably. If a problem arises, it will be reported to the corporate officer in charge in a timely manner. In the event of a natural disaster or other risk that could significantly impact business, a Crisis Management Headquarters, headed by the president, will be established to manage the crisis.

Initiatives Related to Transparency in Relationships with Medical Institutions and Other Parties

The mission of a pharmaceutical company is to contribute to the health and welfare of people around the world through ongoing research and the development of high-value new drugs that address medical needs and by providing stable supplies of those drugs. To fulfill this mission, partnerships with pharmaceutical companies, research laboratories, and medical institutions including universities and others are essential, and we are required to properly manage our relationships where there is a potential conflict of interest with pharmaceutical companies.

Against this backdrop, the ct パチスロ Group has established the Guidelines for Transparency of Relationships between Corporate Activities and Medical Institutions, etc., and the Guidelines on Collaboration with Patient Groups and Transparency of Their Activities. In accordance with these guidelines, we disclose information about funding to medical institutions, patient groups, and others on our website.